Press releases & news


2cureX releases new information brochure



Today 2cureX has released a new information brochure. The brochure is available for download here. 
2cureX – teaser-May 2018 (.PDF)

Certified Adviser
Sedermera Fondkommission is the Certified Adviser of 2cureX.

For more information about 2cureX:
Ole Thastrup, CEO
Phone: +45 22 11 53 99

About 2cureX
2cureX has developed IndiTreat® (Individual Treatment Design) – a patented method for selecting the right drug for the right patient, thereby improving cancer treatment. Initially, IndiTreat® is targeted towards colorectal cancer; but the method is applicable to additional cancer indications (e.g. ovarian, breast and kidney cancer). The company is listed at the Nasdaq First North stock exchange in Stockholm (symbol “2CUREX”).

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail:

Privacy Policy | Imprint